Carlos Jardim
Overview
Explore the profile of Carlos Jardim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gualandro D, Fornari L, Caramelli B, Abizaid A, Gomes B, Tavares C, et al.
Arq Bras Cardiol
. 2024 Oct;
121(9):e20240590.
PMID: 39442131
No abstract available.
2.
Moura D, Pais H, Lourenco P, Jardim C
J Spine Surg
. 2024 Oct;
10(3):450-467.
PMID: 39399081
Background: The effective treatment of post-traumatic vertebral osteonecrosis continues to be an under discussion and controversial subject. Armed kyphoplasty with expansive intravertebral implants is an emerging procedure, which, in theory,...
3.
Piloto B, Fernandes C, Jardim C, Castro M, Alves-Jr J, Souza R
J Bras Pneumol
. 2023 May;
49(3):e20220337.
PMID: 37132695
Idiopathic pulmonary arterial hypertension (PAH) patients with a positive response to acute vasodilator challenge and a clinical response to calcium channel blockers (CCBs) for at least one year are traditionally...
4.
Moura D, Isidoro D, Lourenco P, Jardim C
J Spine Surg
. 2023 Jan;
8(4):462-476.
PMID: 36605993
Background: The optimal treatment of osteoporotic vertebral fractures is still a controversial and under discussion topic. Armed kyphoplasty with expansive intravertebral implants is an emerging procedure, which, in theory, it...
5.
Orozco-Levi M, Caneva J, Fernandes C, Restrepo-Jaramillo R, Zayas N, Conde R, et al.
Pulm Circ
. 2022 May;
12(1):e12012.
PMID: 35506085
Treatment for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in Latin America differs between countries, with regard to disease etiology, health insurance coverage, and drug availability. A group of...
6.
Fernandes C, Calderaro D, Luppino Assad A, Salibe-Filho W, Kato-Morinaga L, Hoette S, et al.
Arq Bras Cardiol
. 2021 Oct;
117(4):750-764.
PMID: 34709302
In the last decades, important advances have been made in the treatment of pulmonary arterial hypertension (PAH), a severe, progressive, incurable, and potentially fatal disease. For an adequate therapy, correct...
7.
Castro M, Piloto B, Fernandes C, Jardim C, Filho W, Oleas F, et al.
PLoS One
. 2020 May;
15(5):e0233063.
PMID: 32442171
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism, characterized by non-resolving fibro-thrombotic obstructions of large pulmonary arteries. Pulmonary endarterectomy (PEA) is the treatment of choice...
8.
Fernandes C, Luppino Assad A, Alves-Jr J, Jardim C, Souza R
Respiration
. 2019 Aug;
98(3):253-262.
PMID: 31390642
Acute pulmonary embolism (PE) impairs hemodynamics, gas exchange, and lung mechanical capacity. Considering PE pathophysiology, most attention has been paid to hemodynamic impairment. However, the most prevalent symptoms in PE...
9.
Fernandes C, Jardim C, Souza R
Curr Opin Pulm Med
. 2019 Aug;
25(5):391-397.
PMID: 31365371
Purpose Of Review: To understand the global distribution of different forms of pulmonary hypertension. Recent Findings: Different registries have explored the epidemiological characteristics of pulmonary hypertension. Interestingly, there is a...
10.